Relapsed Multiple Myeloma

DBCOND0031510Cardiovascular DiseasesHemic and Lymphatic Diseases

Relapsed Multiple Myeloma is the indication for 14 drugs in DrugBank. It is covered by 30 curated, structured indications.

Also known as
Multiple Myeloma in Relapse · Relapse Multiple Myeloma · Multiple Myeloma, Relapsed · relapsed multiple mieloma
Classified under
Indicated drugs

Resolves to

Vocabularies
ICD-10C90.02SNOMED CT452291000124109UMLSC2349261

What you can answer from here — as of October 07, 2026

14Indicated drugsWith each drug's targets and mechanism
Listed above
30Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
149Clinical trialsPhase, status and sponsor resolved per trial
Sign in
4Drugs reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Relapsed Multiple Myeloma share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In